Sign In
Buy RGEN
$149.78
+2.72 (+1.85%)
At Close: Aug 04, 2026
Delta Investment Management LLC Buys Shares of 50,717 Repligen Corporation $RGEN
05:25am, Thursday, 01'st Jan 2026
Delta Investment Management LLC purchased a new position in Repligen Corporation (NASDAQ: RGEN) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN
03:18am, Monday, 22'nd Dec 2025
Assenagon Asset Management S.A. purchased a new position in Repligen Corporation (NASDAQ: RGEN) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commi
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
07:30am, Thursday, 18'th Dec 2025
WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate i
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
07:30am, Tuesday, 16'th Dec 2025
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new h
AWM Investment Company Inc. Sells 12,000 Shares of Repligen Corporation $RGEN
03:51am, Saturday, 13'th Dec 2025
AWM Investment Company Inc. lowered its position in shares of Repligen Corporation (NASDAQ: RGEN) by 21.1% in the second quarter, according to its most recent disclosure with the SEC. The institutiona
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN
04:27am, Thursday, 04'th Dec 2025
Edgestream Partners L.P. purchased a new stake in Repligen Corporation (NASDAQ: RGEN) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Comm
Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
04:43pm, Wednesday, 03'rd Dec 2025
Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Advisors Asset Management Inc. Cuts Holdings in Repligen Corporation $RGEN
03:16am, Monday, 01'st Dec 2025
Advisors Asset Management Inc. lowered its position in Repligen Corporation (NASDAQ: RGEN) by 20.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm
Repligen Corporation to Present at Evercore Healthcare Conference
07:30am, Wednesday, 26'th Nov 2025
WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participat
Repligen Corporation (RGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
02:48pm, Tuesday, 18'th Nov 2025
Repligen Corporation ( RGEN ) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 12:40 PM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Steven Chehames Confere
Repligen Corporation (RGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript
11:18am, Tuesday, 18'th Nov 2025
Repligen Corporation ( RGEN ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:30 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants M
Repligen: Rare Growth In The Biopharma Supplies Industry
03:28am, Friday, 14'th Nov 2025
Repligen stands out as a leading bioprocess supplier, benefiting from secular growth in biologics and industry patent expirations. RGEN's strong balance sheet, recurring organic growth, and strategic
Repligen Corporation (RGEN) Presents at Stifel 2025 Healthcare Conference Transcript
03:11pm, Tuesday, 11'th Nov 2025
Repligen Corporation ( RGEN ) Stifel 2025 Healthcare Conference November 11, 2025 10:00 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants Daniel Ari
Repligen Corporation (RGEN) Presents at UBS Global Healthcare Conference 2025 Transcript
01:41pm, Monday, 10'th Nov 2025
Repligen Corporation ( RGEN ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Jacob Johnson - Vice President of
RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down
12:21pm, Wednesday, 29'th Oct 2025
Repligen posts strong Q3 results with revenue growth and an earnings beat, yet shares dip as tighter EPS guidance tempers investor optimism.
